United Airlines’ 2026 Earnings Cut Shows How Higher Oil Costs Are Hitting Airline Margins
United Airlines cut its 2026 outlook as fuel costs escalated, highlighting the tension between resilient travel demand and tighter airline m…
Truist Earnings Miss Highlights Loan-Sale Impact as Carlyle Deal Reshapes Lightstream
Truist missed third-quarter earnings expectations after a loan sale affected results, while its Lightstream sale to Carlyle adds a balance-s…
Morgan Stanley’s Trading Strength Delivers Earnings Beat Amid Market Volatility
Morgan Stanley exceeded quarterly earnings estimates as equity trading benefited from volatility, even as hotter inflation revived rate-hike…
Citigroup Earnings Beat Highlights Strength in Investment Banking and Wealth Revenue
Citi’s estimate-beating earnings were supported by investment banking, services and wealth revenue, offering a constructive signal for bank …
UnitedHealth Raises 2026 Earnings Outlook Despite Medical-Cost Pressure: What $UNH Investors Should Watch
UnitedHealth lifted its 2026 adjusted earnings outlook to at least $20.50 per share despite elevated medical costs.
Citi and Wells Fargo Earnings Offer a Mixed but Constructive Read on U.S. Banks
Citi’s revenue-led beat and Wells Fargo’s mixed results offer contrasting signals on U.S. bank-sector stability ahead of Fed decisions.
PepsiCo Stock Rallies After Guidance Cut as Investors Weigh Turnaround Potential
PepsiCo shares rallied after lower guidance, putting improving sales growth and demand investments at the center of the turnaround debate.
Lockheed Martin Secures $1.2 Billion Army Contract Amid Geopolitical Tensions
Lockheed Martin's recent $1.2 billion contract win signals a bullish outlook in defense amidst rising geopolitical tensions.
Macy's Q2 Earnings Beat: A Sign of Retail Sector Resilience?
Macy's beats Q2 earnings expectations and raises full-year guidance, signaling a potential turnaround in the retail sector.
Eli Lilly's Strategic Acquisition of Merida Biosciences: A Look at the Future of Its Drug Pipeline
Eli Lilly is set to acquire Merida Biosciences for $2.875 billion, signaling a bold move in its drug pipeline expansion.
IMAX's Box Office Surge: An Investor's Guide to the 'Awakening' Trend
IMAX capitalizes on premium format demand as 'The Odyssey' drives revenue growth, signaling potential earnings momentum in the recovering le…
Apple's Subscription Price Hikes: A Sign of Strong Demand or Consumer Pushback Risk?
Apple raises subscription prices for its services, prompting investors to evaluate demand and consumer sentiment.